Medicare Enrolled
Dr. Manjesh Lingamurthy, M.D.
Hematology & Oncology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lingamurthy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lingamurthy? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lingamurthy
Dr. Manjesh Lingamurthy is a hematology & oncology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Lingamurthy performed 70,526 Medicare services across 1,821 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lingamurthy received a total of $21,819 from 110 pharmaceutical and/or device companies across 1241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lingamurthy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 12% volume in FL$ $21,819 industry payments
Medicare Practice Summary
Medicare Utilization ↗70,526
Medicare services
Top 12% in FL for hematology & oncology
1,821
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,712 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells | 23,100 | $0 | $1 |
| Iron infusion (Injectafer) | 15,750 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 12,180 | $18 | $47 |
| Epoetin alfa injection (Retacrit) for anemia | 5,370 | $5 | $12 |
| Iron infusion (Monoferric) | 4,700 | $17 | $43 |
| Dexamethasone injection (steroid) | 1,886 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,632 | $8 | $16 |
| Injection, cetirizine hydrochloride, 0.5 mg | 920 | $12 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 860 | $1 | $2 |
| Office visit, established patient (20-29 min) | 623 | $64 | $182 |
| Injection of additional new drug or substance into vein | 540 | $12 | $31 |
| Office visit, established patient (30-39 min) | 517 | $91 | $256 |
| Drug injection, under skin or into muscle | 504 | $11 | $28 |
| Office visit, established patient, complex (40-54 min) | 338 | $131 | $363 |
| Administration of chemotherapy into vein, 1 hour or less | 263 | $98 | $267 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 183 | $54 | $149 |
| Injection, zoledronic acid, 1 mg | 183 | $6 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 176 | $48 | $132 |
| Injection, diphenhydramine hcl, up to 50 mg | 169 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 127 | $22 | $57 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 116 | $1 | $4 |
| Administration of additional new drug or substance into vein, 1 hour or less | 76 | $49 | $130 |
| Irrigation of implanted venous access drug delivery device | 51 | $17 | $52 |
| New patient office visit, complex (60-74 min) | 45 | $169 | $447 |
| Infusion into a vein for hydration, each additional hour | 43 | $10 | $25 |
| Infusion, normal saline solution , 1000 cc | 42 | $2 | $5 |
| Infusion into a vein for hydration, 31-60 minutes | 38 | $25 | $67 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | 34 | $125 | $333 |
| Drawing of blood for a medical problem | 28 | $67 | $198 |
| Hospital follow-up visit, high complexity | 18 | $94 | $240 |
| New patient office visit (45-59 min) | 14 | $121 | $338 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.4% high complexity
65.8% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,819
Total received (2018-2024)
Avg $3,117/year across 7 years
Top 24% in FL for hematology & oncology
110
Companies
1,241
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,138 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$681 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,881
2023$3,432
2022$3,740
2021$2,691
2020$3,085
2019$2,905
2018$2,084
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,300
PFIZER INC.
$1,321
Merck Sharp & Dohme Corporation
$1,136
Janssen Biotech, Inc.
$906
Daiichi Sankyo Inc.
$902
Genentech USA, Inc.
$888
Lilly USA, LLC
$827
E.R. Squibb & Sons, L.L.C.
$750
Celgene Corporation
$611
Incyte Corporation
$598
Merck Sharp & Dohme LLC
$555
GlaxoSmithKline, LLC.
$545
Seagen Inc.
$507
GENZYME CORPORATION
$484
AstraZeneca Pharmaceuticals LP
$434
Takeda Pharmaceuticals U.S.A., Inc.
$417
BeiGene USA, Inc.
$395
Regeneron Healthcare Solutions, Inc.
$394
Gilead Sciences, Inc.
$365
Bayer HealthCare Pharmaceuticals Inc.
$356
Astellas Pharma US Inc
$331
ARRAY BIOPHARMA INC
$255
Eisai Inc.
$255
EMD Serono, Inc.
$253
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
Foundation Medicine, Inc.
$235
Kite Pharma, Inc.
$214
JAZZ PHARMACEUTICALS INC.
$201
SOBI, INC
$175
Rigel Pharmaceuticals, Inc.
$172
ABBVIE INC.
$170
Clovis Oncology, Inc.
$168
PUMA BIOTECHNOLOGY, INC.
$163
EISAI INC.
$158
Exelixis Inc.
$156
Pharmacyclics LLC, An AbbVie Company
$156
PharmaEssentia USA Corporation
$149
Karyopharm Therapeutics Inc.
$148
Dova Pharmaceuticals
$145
TerSera Therapeutics LLC
$144
Amgen Inc.
$132
AbbVie Inc.
$128
Seattle Genetics, Inc.
$114
Myovant Sciences Inc.
$102
Myriad Genetic Laboratories, Inc.
$96
AVEO Pharmaceuticals, Inc.
$95
SERVIER PHARMACEUTICALS LLC
$90
Mirati Therapeutics, Inc.
$83
Sobi, Inc
$83
Global Blood Therapeutics, Inc.
$82
Aveo Pharmaceuticals, Inc.
$79
Fennec Pharmaceuticals, Inc.
$77
Immunomedics, Inc.
$77
AbbVie, Inc.
$75
Puma Biotechnology, Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$74
Sun Pharmaceutical Industries Inc.
$73
Agios Pharmaceuticals, Inc.
$68
Helsinn Therapeutics (U.S.), Inc.
$66
Sysmex Inostics Inc
$63
Jazz Pharmaceuticals Inc.
$60
Amneal Pharmaceuticals LLC
$60
CTI BioPharma Corp.
$59
TAIHO ONCOLOGY, INC.
$55
ADC Therapeutics America, Inc.
$53
Kyowa Kirin, Inc.
$52
Array BioPharma Inc.
$50
G1 Therapeutics, Inc.
$48
Celltrion USA Inc.
$47
GE HealthCare
$46
Sumitomo Pharma America, Inc.
$46
Stemline Therapeutics Inc.
$46
Genmab U.S., Inc.
$46
TOLMAR Pharmaceuticals, Inc.
$41
Acrotech Biopharma LLC
$41
Pharmacyclics LLC, an AbbVie Company
$40
EUSA Pharma (US) LLC
$40
Fortovia Therapeutics, Inc.
$39
Apellis Pharmaceuticals, Inc.
$39
AMAG Pharmaceuticals, Inc.
$37
Coherus Biosciences Inc.
$30
INSYS Therapeutics Inc
$30
MEDIVATION FIELD SOLUTIONS LLC
$27
Sirtex Medical Inc
$27
Alexion Pharmaceuticals, Inc.
$25
Azurity Pharmaceuticals, Inc.
$23
Secura Bio, Inc.
$23
Heron Therapeutics, Inc.
$22
Epizyme, Inc.
$21
Acrotech Biopharma Inc.
$21
Telix Pharmaceuticals
$20
Midatech Pharma US Inc
$19
Pharmacosmos Therapeutics Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
ORGANOGENESIS INC.
$18
Blueprint Medicines Corporation
$18
Tempus AI, Inc
$17
Epizyme, Inc.,
$16
Servier Pharmaceuticals LLC
$15
Advanced Accelerator Applications
$15
Taiho Oncology, Inc.
$14
SANOFI-AVENTIS U.S. LLC
$14
Boston Scientific Corporation
$14
Acceleron Pharma, Inc.
$14
Medtronic USA, Inc.
$13
MAYNE PHARMA INC.
$13
MorphoSys, US Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$12
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Spectrum Pharmaceuticals Inc.
$12
Top 3 companies account for 21.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gelclair · HEMADY · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OJJAARA · ONCASPAR · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · Puraply · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYNCHROMED · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · WATCHMAN · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · Zuplenz · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $31 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
17
Per 100K population
3.8
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lingamurthy is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lingamurthy experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Lingamurthy performed 23,100 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lingamurthy receive payments from pharmaceutical companies?
Yes. Dr. Lingamurthy received a total of $21,819 from 110 companies across 1,241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lingamurthy's costs compare to other hematology & oncologys in Sarasota?
Dr. Lingamurthy's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lingamurthy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Sarasota
Browse hematology & oncologys in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology